NCT00868296
Open Label Safety Study of Enteric-Coated Spheroid Suspension in Infants Aged Less Than 12 Months With Presumed Gastroesophageal Reflux Disease (GERD)
See it on ClinicalTrials.gov ↗58 people
44.8%
55.2%
26 womenmiddle line = equal numbers32 men
- Phase
- PHASE3
- Paid for by
- Wyeth is now a wholly owned subsidiary of Pfizer
- Finished
- 2008-03
- Health conditions
- Gastroesophageal Reflux
- Who could join
- Anyone
- Ages
- 1 Day – 12 Months
- Average age
- mean 5.92 months
- Age 65+
- Not reported
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Not reported
Women left out
- Age limit under 65
Older women were turned away, even though they often take this medicine.
“Maximum age: 12 Months.”
Study titles and rules are shown in their original English.